CN Patent

CN105246457A — 局部氨苯砜和氨苯砜/阿达帕林组合物及其使用方法

Assigned to Allergan Inc · Expires 2016-01-13 · 10y expired

What this patent protects

氨苯砜和氨苯砜/阿达帕林组合物可适用于治疗多种皮肤病学病状。本公开的组合物包括在聚合增粘剂中的氨苯砜和/或阿达帕林。本发明组合物可进行调整来优化氨苯砜的皮肤递送特性，以有效地治疗皮肤病学病状并且改善涂覆至皮肤的药物产品的效力。使用聚合增粘剂提供相对于无聚合增粘剂的组合物具有增加的二甘醇一乙醚浓度的组合物。

USPTO Abstract

氨苯砜和氨苯砜/阿达帕林组合物可适用于治疗多种皮肤病学病状。本公开的组合物包括在聚合增粘剂中的氨苯砜和/或阿达帕林。本发明组合物可进行调整来优化氨苯砜的皮肤递送特性，以有效地治疗皮肤病学病状并且改善涂覆至皮肤的药物产品的效力。使用聚合增粘剂提供相对于无聚合增粘剂的组合物具有增加的二甘醇一乙醚浓度的组合物。

Drugs covered by this patent

Patent Metadata

Patent number
CN105246457A
Jurisdiction
CN
Classification
—
Expires
2016-01-13
Drug substance claim
No
Drug product claim
No
Assignee
Allergan Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.